Abstract: Compositions, methods and kits are provided for altering the properties of a biological surface using particles such as, for instance, calcium based particles in combination with an agent that binds to the biological surface. Properties such as color, sheen, texture, strength, and odor of biological surfaces such as teeth and bone are alterable.

Abstract: The photocatalytic apatite composition and its production method are disclosed. The photocatalytic apatite comprises a photocatalytic apatite having incorporated into the apatite crystal structure thereof a metal oxide having a photocatalytic action, such as titanium oxide, and a metal ion having an antimicrobial property, such as a silver ion or a copper ion. The photocatalyst apatite composition is capable of maintaining excellent decomposition and adsorption properties for various organic materials such as VOCs or specific adsorbing substances such as a virus for a long time and, at the same time, expressing an excellent antimicrobial property in a dark place as well as under daylight.

Abstract: A method for removing and recovering phosphorus from a spent adsorbent medium to result in a regenerated medium and a phosphorus-containing solution useful as a fertilizer.

Abstract: The present invention provides a broad band light absorbing photocatalyst which has a high absorptivity not only for visible light but also, in particular, for ultraviolet light, exhibits photocatalytic activity in response to a broad band light over a long period, has a high adsorptivity for objects to be decomposed, and can exhibit oxidative decomposition effect, antibacterial effect, antifouling effect, etc. The broad band light absorbing photocatalyst of the present invention includes an apatite having photocatalytic activity, a visible light absorbing metal atom and an ultraviolet light absorbing metal atom and the ultraviolet light absorbing metal atom is at least one of tungsten (W) and vanadium (V).

Abstract: Zirconium phosphate particles are synthesized by providing a solution of zirconium oxychloride in an aqueous solvent, adding at least one oxygen-containing additive to the solution, the oxygen-containing additive being selected to form a complex with zirconium ions in the solution of zirconium oxychloride and thereby reduce hydration of the zirconium ions, and combining this solution with phosphoric acid or a phosphoric acid salt to obtain zirconium phosphate particles by sol gel precipitation.

Abstract: The present invention relates to a solid phosphoric acid catalyst and a process for conversion of hydrocarbons using a solid phosphoric acid catalyst. The solid phosphoric acid catalyst comprises silicon orthophosphate, and has a silicon orthophosphate to silicon pyrophosphate ratio of at least about 5:1. The total pore volume of the solid phosphoric acid catalyst is at least about 0.17 cm3 per gram of catalyst, of which at least about 0.15 cm3 per gram is contributed by pores with diameter of at least about 10,000 ?.

Abstract: A cement powder is disclosed that contains reactive tricalcium phosphate nanoparticles and other ingredients required to form a cementous material. Methods of making the reactive tricalcium phosphate nanoparticles, the cement powder, the cement paste, and cured cement are also provided, as are methods and articles for using the cement.

Abstract: This invention provides novel composite biomaterials having excellent bioadaptability and bone inductivity and a process for producing the same. The composite biomaterials comprise hydroxyapatite, collagen, and alginate and have microporous structures in which the c-axis of the hydroxyapatite is oriented along the collagen fibers.

Abstract: The present invention is directed to calcium phosphates in granular form having an X-ray diffraction pattern characteristic of hydroxyapatite in which a portion of the anions of the crystal lattice are substituted with carbonate anions and which have good compressibility and flow properties in direct compression applications. The invention is also directed to the methods for preparing the calcium phosphate aforesaid granules characterized in that the methods include the processing of a brushite dicalcium phosphate solution having a specified particle size distribution using a solution of an alkaline earth carbonate for a sufficient period of time to allow the transformation of the brushite calcium phosphate into hydroxyapatite calcium phosphate.

Abstract: A ceramic powder of non-agglomerated non-aggregated phase-pure hydroxyapatite having a controllable morphology. Also presented is a film of phasepure crystalline hydroxyapatite grains having a controllable morphology. Methods for preparing the same are also provided.

Abstract: Improved solid acid electrolyte materials, methods of synthesizing such materials, and electrochemical devices incorporating such materials are provided. The stable electrolyte material comprises a solid acid capable undergoing rotational disorder of oxyanion groups and capable of extended operation at elevated temperatures, that is, solid acids having hydrogen bonded anion groups; a superprotonic, trigonal, tetragonal, or cubic, disordered phase; and capable of being operating at temperatures of ˜100° C. and higher.

Abstract: Nano-particles of calcium and phosphorous compounds are made in a highly pure generally amorphous state by spray drying a weak acid solution of said compound and evaporating the liquid from the atomized spray in a heated column followed by collection of the precipitated particles. Hydroxy apetite (HA) particles formed by such apparatus and methods are examples of particle manufacture useful in bone and dental therapies.

Abstract: This invention is based on the preparation of new solid acid triphosphates with compositions of the general formula M(IV)(HPO4)(H2PO4)2, where M(IV) is a tetravalent metal or a mixture of tetravalent metals. These compounds are insoluble in water the greater part of most organic solvents. They show a high non-water assisted protonic conductivity (about 0.01-0.04 S/cm at 100° C. and a relative humidity lower than 1%). These compounds can be used as proton conduction separators in electrochemical devices, to operate at low relative humidity values, as for example in different fuel cells, protonic pumps for electrochemical hydrogenation and dehydrogenation of organic compounds, or for hydrogen production from hydrogenated organic compounds by electro-reforming, or also for removing hydrogen from equilibrium reactions. These compounds can also be used in electrochemical sensors, in super capacitors and as acid catalysts in non-aqueous or anhydrous gaseous phases.

Abstract: Phosphate rock is reacted with phosphoric acid to produce monobasic calcium phosphate. Monobasic calcium phosphate is reacted with ammonium carbonate to produce ammonium phosphate. Dibasic calcium phosphate is also produced as a by-product when monobasic calcium phosphate reacting with ammonium carbonate. The dibasic calcium phosphate is reacted with sulfuric acid to produce phosphoric acid. The phosphoric acid is used to react with phosphate rock. Ammonium sulfate or ammonium hydroxide may be used instead of ammonium carbonate. Phosphate other than ammonium phosphate can be produced if calcium phosphate is reacted with x-y to produce x-phosphate, where x is lithium, sodium, ammonium or potassium and y is carbonate, bicarbonate hydroxide or sulfate.

Abstract: Methods of making porous calcium phosphate bone replacement materials are discussed.

Abstract: The invention concerns microgranules produced from calcium phosphate materials. The invention also concerns a method for producing said microgranules. The inventive microgranules are characterized by a very narrow particle size distribution.

Abstract: A film containing a photo-catalyst apatite contains an inorganic coating main material, and a powdered photo-catalyst apatite and powdered titanium oxide that disperse within the inorganic coating main material, in which the total content of the photo-catalyst apatite and the titanium oxide is 0.01-5 wt %.

Abstract: The rod-shaped apatite crystals of the formula Ca5(PO4)3(OH)xFy have the following features a) the length-to-breadth ratio of the crystals is at least ?5 and b) x+y=1, where if x or y?0 the total amount of the crystals is present as a mixture of individual hydroxyapatite crystals and fluoroapatite crystals and/or as mixed crystals, such that, based on the total amount of the crystals, (1?x)·100% of the hydroxide ions present if y=0 are replaced by fluoride ions. The invention furthermore describes dispersions which contain such rod-shaped apatite crystals, and a process for the preparation of the dispersions or of the apatite crystals.

Abstract: A new and useful method of simultaneously producing and granulating anhydrous dicalcium phosphate is provided. Such a method entails the reaction of concentrated phosphoric acid with a powdered material of lime and/or calcium carbonate in substantially equal stoichiometric amounts, with subsequent, mixing, drying, milling, and sieving to provide the correct target particle size range for the resultant granulated materials. Such specifically produced granulated anhydrous dicalcium phosphate materials exhibit very high available calcium levels, excellent flow characteristics, and very high capability for compression into tablets. Products including such particularly produced granulated anhydrous dicalcium phosphate materials are also encompassed within this invention.

Abstract: Improved solid acid electrolyte materials, methods of synthesizing such materials, and electrochemical devices incorporating such materials are provided. The stable electrolyte material comprises a solid acid in a eulytine structure capable of undergoing rotational disorder of oxyanion groups and capable of extended operation at elevated temperatures, that is, solid acids having hydrogen bonded anion groups; a superprotonic disordered phase; and capable of operating at temperatures of ˜100° C. and higher.

Abstract: Provided is a method for production of nanocrystalline hydroxyapatite particles, and nanocrystalline hydroxyapatite particles produced according to the method. The nanocrystalline hydroxyapatite particles exhibit substantially superior cell transformation abilities as compared to known and commercially-available calcium phosphate kits. The nanocrystalline hydroxyapatite particles also find use in tissue engineering applications, for example bone and tooth engineering and repair applications.

Abstract: A mechanism and technological process for synthesizing nano-sized crystalline hydroxyapatite.

Abstract: The rod-shaped apatite crystals of the formula Ca5(PO4)3(OH)xFy have the following features a) the length-to-breadth ratio of the crystals is at least ?5 and b) x+y=1, where if x or y?0 the total amount of the crystals is present as a mixture of individual hydroxyapatite crystals and fluoroapatite crystals and/or as mixed crystals, such that, based on the total amount of the crystals, (1?x)·100% of the hydroxide ions present if y=0 are replaced by fluoride ions. The invention furthermore describes dispersions which contain such rod-shaped apatite crystals, and a process for the preparation of the dispersions or of the apatite crystals.

Abstract: The present invention provides a novel process for producing a calcium phosphate cement or filler which hardens in a temperature dependent fashion in association with an endothermic reaction. In the reaction a limited amount of water is mixed with dry calcium phosphate precursors to produce a hydrated precursor paste. Hardening of the paste occurs rapidly at body temperature an is accompanied by the conversion of one or more of the reactants to poorly crystalline apatitic calcium phosphate. The hardened cements, fillers, growth matrices, orthopedic and delivery devices of the invention are rapidly resorbable and stimulate hard tissue growth and healing.

Abstract: A method of manufacturing a powder, by which it is possible to adjust the strength of the obtained powder is provided. The manufacturing method of a powder involves a step of preparing a slurry containing agglomerated particles of a synthetic material which is produced by reacting a first material and a second material under agitation, and a step of drying the slurry to obtain a powder of the synthetic material. The method has a feature that the particle size of the agglomerated particles is adjusted by, in the step of preparing a slurry, controlling agitation power for agitating the slurry. In the step of preparing a slurry, it is preferable that the slurry is initially agitated at a first agitation power, and at the time when the viscosity of the slurry approaches its maximum value, or at the time when the pH value of the slurry reaches the vicinity of the isoelectric point of the synthetic material, the agitation power is lowered from the first agitation power to a second agitation power.

Abstract: A process is provided for the production of dicalcium phosphate form a phosphate source material in which a solution of phosphoric acid is produced by the action of a suitable mineral acid, generally sulphuric acid, on a phosphate source material. Calcium fluoride is precipitated at a pH of between 3.5 and 4.5 followed by hydrolyzing the solution by diluting it with water to a ratio of approximately 1:7 to about 1:10 monocalcium phosphate to water at a temperature of approximately 40 degrees Centigrade to form a primary precipitate containing substantially all of the fluoride present as CaF2 together with some dicalcium phosphate and a primary calcium and phosphate containing solution. The primary precipitate is dissolved, the pH adjusted to form 3.5 to 4.5 and the hydrolyzation repeated to form a secondary precipitate containing substantially all of the fluoride present as CaF2 together with some dicalcium phosphate and a secondary calcium and phosphate containing solution.

Abstract: In a process of eluting phosphorus from sludge into a liquid phase and recovering the phosphorus efficiently, cell walls of microorganisms in the sludge are ruptured by a process selected from crushing sludge (for example, treating with an ultrasonic wave homogenizer), treating with ozone, and treating with heat. Then the liquid phase is treated with alkali, thereby eluting the phosphorus into a liquid phase efficiently in a short time. By coagulating and precipitating, the phosphorus eluted into the liquid phase is recovered.

Abstract: Methods of making porous calcium phosphate bone replacement materials are discussed.

Abstract: A bone replacement material and therapy comprises the combination of calcium phosphate compounds and two or more soluble fillers in the form of fibers, mesh or other materials which have the dual functions of reinforcing an in vivo implant while dissolving at a programmed rate to form macropores capable of receiving natural bone ingrowth.

Abstract: Disclosed are a silicon- and magnesium-containing porous hydroxyapatite, and a preparation method thereof which comprises the steps of performing a hydrothermal treatment of a natural coral and performing a solvothermal treatment.

Abstract: The present invention describes a procedure for the removal of sodium sulphate from a phosphate solution that has been used for absorption of SO2 from flue gases, in which a precipitate forms when the absorption solution is regenerated by evaporation. In this procedure a part of the precipitate is separated from its solution and treated with water and SO2 for transformation of disodium-hydrogen phosphate into monosodium dihydrogen phosphate in the aqueous solution. The sodium sulphate remains undissolved and is removed by filtration. The filtrate is then added back to the main process.

Abstract: A zirconium phosphate compound having a Zr:P ratio of from about 1.80-2.0 to 1, which compound's H-form exhibits a single peak at ?13.7±0.5 ppm in the 31P NMR spectra. The compound is useful as a catalyst, catalyst support and ion exchange media having a high affinity for cobalt and nickel ions.

Abstract: A bone replacement material and therapy comprises the combination of calcium phosphate compounds and two or more soluble fillers in the form of fibers, mesh or other materials which have the dual functions of reinforcing an in vivo implant while dissolving at a programmed rate to form macropores capable of receiving natural bone ingrowth.

Abstract: The invention relates to zirconium phosphate of H form which is characterized by a 31P NMR spectra comprising peaks at ?4.7 ppm, ?12.8 ppm and ?17.0 ppm (all peaks being in a range of ±0.5 ppm). Also featured is a Na form of the material. The zirconium phosphate material is characterized by a unique surface area, pore size distribution and surface morphology, as well as by an affinity for NH4+ ions and moisture insensitivity. Also featured is hafnium phosphate characterized by moisture insensitivity. The zirconium phosphate may be amorphous and possess a framework-type structure. The inventive method of making zirconium phosphate includes the steps of heating an aqueous mixture including a zirconium compound and a phosphorous-containing reagent at a temperature of at least 120° C. to form a reaction product, and treating the reaction product with acid at a temperature of at least 60° C.

Abstract: The invention relates a process for producing an alkali metal nitrate and an alkali metal phosphate in the same process from a phosphate raw material and a nitrate raw material comprising the steps of: a) reacting the phosphate raw material with the nitrate raw material to provide an aqueous nitrophosphate feed, optionally followed by the separation of solid material, b) introducing the aqueous nitrophosphate feed into a first ion exchange step comprising an alkali metal-loaded cationic exchange resin for exchanging cations present in the feed with alkali metal ions present on the resin to obtain a stream enriched in alkali metal ions, c) subjecting the stream from step (b) to a first crystallization under such conditions that an alkali metal nitrate is crystallized and separating the crystallized alkali metal nitrate from the mother liquor, d) introducing the mother liquor from step (c) into a second ion exchange step comprising an alkali metal-loaded cationic exchange resin for exchanging cations present

Abstract: The invention relates to a hydroxylapatite material containing phosphate wherein the microporous structure of algae hard-tissue raw material is retained in the end product and which can be obtained by reacting an organic compound devoid of algae hard-tissue in an alkaline aqueous phosphate solution by adding magnesium ions at an elevated temperature. The invention also relates to a method for the production of said hydroxylapatite material containing tricalcium phosphate, which is characterized in that it is especially well resorbed in the body, is especially suitable as a bone substitute material or as a carrier material for active ingredients. Said material can also be used as a filter material.

Abstract: The present invention is directed to a synthetic biomaterial compound based on stabilized calcium phosphates and more particularly to the molecular, structural and physical characterization of this compound. The compound comprises calcium, oxygen and phosphorous, wherein at least one of the elements is substituted with an element having an ionic radius of approximately 0.1 to 1.1 ?. The knowledge of the specific molecular and chemical properties of the compound allows for the development of several uses of the compound in various bone-related clinical conditions.

Abstract: A method of making sodium zirconium carbonate is described which involves forming a mixture of zirconium oxychloride with soda ash and then heating at a sufficient temperature and for a sufficient time to form the sodium zirconium carbonate. Subsequent washing and filtration steps can further form parts of this process. A novel sodium zirconium carbonate is further described which contains from about 2 wt % to about 5 wt % Na+; from about 44 wt % to about 50 wt % ZrO2; from about 12 wt % to about 18 wt % CO32−; and from about 32 wt % to about 35 wt % H2O. Methods of making zirconium basic carbonate are further described which involve titrating an aqueous slurry of sodium zirconium carbonate to a pH of from about 3.5 to about 4.0 with an acidic agent wherein the sodium zirconium carbonate has a moisture content of from about 15% to about 25% LOD in solid form. The process further involves washing the aqueous slurry containing the formed zirconium basic carbonate with water.

Abstract: A method for controlling organisms which comprises growing, decreasing, activating or inactivating cells, bacteria, viruses or fungi at an N-surface or a P-surface of a ceramic which is formed by treating the ceramic by polarization; and a material for controlling organisms, a method for selective adsorption of proteins, a material for selective adsorption of proteins, a cement material for filling bones and dental applications and a biomaterial, in which the ceramic treated by polarization is utilized. By utilizing difference in properties among surfaces of the ceramic treated by polarization, growth, decrease, activation or inactivation of organisms such as cells, bacteria, viruses or fungi can be controlled. Therefore, the above methods and materials are useful in the medical, dental and biochemical areas.

Abstract: The present invention relates to a method for preparation of the supersaturated calcium and phosphate ions solution and a method for preparation of the thin film of calcium phosphate crystal on solid surface by using the said solution. Particularly, the lowered temperature and/or the use of suitable buffer system inhibit the nucleation of calcium phosphate in aqueous solution, and thereby highly supersaturated calcium and phosphate ions solution can be prepared. And the thin film of calcium phosphate crystal on solid surface can be prepared with rapidity and good quality of high reactivity and low crystallinity by using the said solution. Also the thin film of calcium phosphate crystal prepared according to the present invention has biocompatibility and can be applied as biomaterials.

Abstract: The combination of erythropoietin and calcium, with or without phosphates, is useful for treating haemochromatoses. A method for treating primary haemochromatoses in a patient involves administering to the patient a combination therapy including an erythropoietin preparation and a calcium preparation, where the erythropoietin preparation and the calcium preparation are each administered from 1 to 5 times weekly. Beneficially, this combination therapy further administers a phosphorus preparation.

Abstract: An additive for synthetic resins is provided which comprises composite particles obtained by depositing a calcium phosphate compound (R) on support particles (M) of a petaloid porous structure. The additive of the present invention provides synthetic resin compositions having excellent transparency, anti-scratch property, anti-blocking property and less discoloration caused by deterioration of resin.

Abstract: Process for the preparation of a vanadium phosphate catalyst comprising treatment of a vanadium compound with formic acid, water and a phosphorus compound.

Abstract: A process for the preparation of a single phase magnesium- and carbonate-substituted hydroxyapatite composition, which process comprises the steps of (i) preparing an aqueous solution containing CO32− and PO43− ions in the substantial absence of cations other than H+ ions; (ii) mixing the solution from step (i) with an aqueous calcium- and magnesium-containing solution or suspension; and (iii) collecting and drying the precipitate formed in step (ii); the ratio of (Ca+Mg/P) in the calcium- and magnesium-containing solution or suspension and the phosphorus-containing solution, when mixed together, being maintained at 1.67, or above. The product of the process is novel and comprises up to 0.5% magnesium and up to 1% of carbonate substituted into the hydroxyapatite structure and which does not contain Na+ or NH4+ ions, the ratio of (Ca+Mg/P) being greater than 1.67.

Abstract: The present invention is directed to a synthetic biomaterial compound based on stabilized calcium phosphates and more particularly to the molecular, structural and physical characterization of this compound. The compound comprises calcium, oxygen and phosphorous, wherein at least one of the elements is substituted with an element having an ionic radius of approximately 0.1 to 1.1 Å. The knowledge of the specific molecular and chemical properties of the compound allows for the development of several uses of the compound in various bone-related clinical conditions.

Abstract: A process for the preparation of a single phase carbonate-substituted hydroxyapatite composition, which process comprises the steps of (i) preparing an aqueous solution containing Co32− and PO43− ions in the substantial absence of cations other than H+ ions: (ii) mixing the solution from step (i) with an aqueous solution or suspension of a calcium compound; and (iii) collecting and drying the precipitate formed in step (ii); the ratio of Ca/P in the calcium-containing solution or suspension and the phosphorus-containing solution, when mixed together, being maintained above 1.67. The product of the process is novel with a Ca/P molar ratio of greater than 1.67 and comprises up to 5% by weight of CO32− ions substituted in the B site or the B and A sites of the hydroxyapatite structure, with at least 50% of the CO32− ions being substituted on the B site. This product does not contain Na+ or NH4+ ions.

Abstract: Compositions including zirconium phosphate particles as well as methods of synthesizing and using same are provided. The zirconium phosphate particles are synthesized through the use of polyphosphate and zirconyl chloride.

Abstract: The present invention provides a method of manufacturing calcium phosphate powder comprising the steps of preparing a mixed material by mixing calcium hydroxide (Ca(OH)2) powder and calcium hydrogenphosphate powder so that a molar ratio (Ca/P) of calcium to phosphor is set to a range of 1.45-1.72; conducting a mixing/milling treatment to the mixed material to cause a soft-mechanochemical compositing reaction thereby to prepare a calcium phosphate precursor; and conducting a heat treatment to thus obtained precursor at a temperature of 600° C. or more thereby to prepare calcium phosphate powder. According to the present invention, the manufacturing process is simple and the manufacturing cost can be remarkably reduced. In addition, fine calcium phosphate powder excellent in characteristics can be easily manufactured in a short time.

Abstract: The present invention provides delivery vehicles comprising a synthetic, poorly crystalline apatite (PCA) calcium phosphate and a biologically active agent. The PCA calcium phosphate offers many advantages over known delivery materials and is particularly useful for delivery of agents to bone sites, the central nervous system, intramuscular sites, subcutaneous sites, interperitoneal sites, and occular sites. The invention also provides methods of preparing delivery vehicles, of altering delivery vehicle characteristics, and of delivering biologically active agents to a site. The invention is useful for both medical and veterinary applications.

Abstract: A method of synthesizing artificial human bone material for use in orthopedic surgery using the chemical reaction of calcium nitrate, ammonium dihydrogen phosphate and ammonium hydroxide to obtain calcium hydroxy apatite.